Watchlist

Watchlist
Aethlon Medical, Inc. (AEMD)
Aethlon Medical, Inc. (AEMD)
Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix
PHOENIX and SAN DIEGO , March 22, 2018 /PRNewswire/ --Exosome Sciences, Inc., a diagnostic subsidiary of Aethlon Medical, Inc. (Nasdaq: AEMD), today announced the initiation of an Institutional Review Board (IRB) approved protocol for a research study involving retired NFL players…
Midday Gainers / Losers (03/21/2018)
CALI +48% . MARA +26% . DXPE +20% . KMPH +16% . GERN +15% . TGEN +15% . NH +15% . ARNA +13% . PRTA +13% . TCCO +12% . More news on: China Auto Logistics Inc., Marathon Patent Group, Inc., DXP Enterprises, Inc., Stocks on the move, , Read more …
Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting
SAN DIEGO , Feb. 12, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that its CEO, Jim Joyce will give a presentation at the 2018 American Society for Microbiology (A…
Aethlon Medical's (AEMD) CEO Jim Joyce on Q3 2018 Results - Earnings Call Transcript
Aethlon Medical, Inc. (AEMD) Q3 2018 Earnings Conference Call February 1, 2018 4:30 PM ET Executives John Marco Managing Director-Core IR Jim Joyce Chief Executive Officer Jim Frakes Chief Financial Officer Analysts Brian Marckx Zacks Inv…
Aethlon Medical reports Q3 results
Aethlon Medical (NASDAQ: AEMD ): Q3 EPS of -$0.08 Revenue of $0.08M Press Release More news on: Aethlon Medical, Inc., Earnings news and commentary, Healthcare stocks news, ,
Aethlon Medical Announces Fiscal 2018 Third Quarter Results
SAN DIEGO , Feb. 1, 2018 /PRNewswire/ --Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal third quarter ended December 31, 2017 . Recent Corporate Developments …
Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018
SAN DIEGO , Jan. 29, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it will issue third quarter results for the fiscal year ended March 31, 2018 at 4:15 pm eastern time o…
Premarket Gainers as of 9:05 am (1/23/2018)
RGSE +39% . More news on: RGS Energy, Inc., ChinaNet Online Holdings, Inc., Aethlon Medical, Inc., Stocks on the move, Read more …
Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes
SAN DIEGO , Jan. 23, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that validation has completed and the opposition period expired for European Patent Number 2591359, enti…
Premarket Gainers as of 9:05 am
LIVE +28% on FY result . More news on: Live Ventures, Marathon Patent Group, Inc., Five Oaks Investment, Stocks on the move, Read more …
Aethlon Medical, Inc. (AEMD)